BridgeBio Pharma, Inc. (BBIO) Net income 2017–2025
BridgeBio Pharma, Inc. (BBIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$732.9MFY2025 · since FY2017: -$43.8M → -$732.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$732.9M | -34.9% |
| FY2024 | -$543.3M | +16.8% |
| FY2023 | -$653.3M | -34.8% |
| FY2022 | -$484.6M | +17.4% |
| FY2021 | -$586.5M | -16.0% |
| FY2020 | -$505.5M | -75.2% |
| FY2019 | -$288.6M | -70.3% |
| FY2018 | -$169.5M | -286.6% |
| FY2017 | -$43.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice